[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:neuroendocrine-tumor":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":118,"states":119},"Neuroendocrine Tumor",17,14,[8,16,23,29,36,43,49,55,61,67,73,79,86,92,99,106,111],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07087054","Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen",[12],"Phase 3","RECRUITING","2026-08-26T02:17:43.321968Z","2026-07-05T05:32:16.731928Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04339036","CapTemY90 for Grade 2\u002F3 NET Liver Metastases",[20],"Phase 2","2026-08-26T02:17:30.145302Z","2026-05-05T02:43:28.885431Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06202066","Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas",[20],"2026-08-03T02:57:18.103669Z","2026-05-05T02:43:29.222571Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06943755","Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors",[33],"Phase 2\u002FPhase 3","2026-08-26T02:19:18.331180Z","2026-05-05T02:35:31.629898Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":41,"content_modified":42},"NCT07070232","A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors",[40],"Phase 1\u002FPhase 2","2026-08-26T02:18:30.351130Z","2026-07-24T01:27:14.894336Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT06943521","A Study of MT-4561 in Patients With Various Advanced Solid Tumors",[40],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:28.477669Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT06881992","A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism",[12],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.217045Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT03412877","Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer",[20],"2026-08-26T02:19:06.150683Z","2026-05-05T02:43:27.262825Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT04199741","PET\u002FCT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56",[40],"2026-08-26T02:18:04.640417Z","2026-07-05T05:32:16.773657Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT00646022","Natural History of Familial Carcinoid Tumor",[],"2026-08-26T02:19:29.119921Z","2026-05-13T02:55:06.040272Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT01416714","Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.072507Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":84,"content_modified":85},"NCT07132645","An Investigational Scan ([68Ga] Ga-FAPI-04 PET\u002FCT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer",[83],"Early Phase 1","2026-08-26T02:16:18.872924Z","2026-05-05T02:35:31.682913Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":90,"content_modified":91},"NCT06788886","Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases",[],"2026-08-26T02:18:26.129155Z","2026-05-05T02:43:28.473348Z",{"nct_id":93,"title":94,"phases":95,"status":13,"updated_at":97,"content_modified":98},"NCT04373564","Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years",[96],"Phase 4","2026-08-26T02:17:39.857430Z","2026-05-05T02:43:28.117085Z",{"nct_id":100,"title":101,"phases":102,"status":103,"updated_at":104,"content_modified":105},"NCT07640737","AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)",[20],"NOT_YET_RECRUITING","2026-08-26T02:15:23.202838Z","2026-06-14T18:39:22.259811Z",{"nct_id":107,"title":108,"phases":109,"status":103,"updated_at":97,"content_modified":110},"NCT05967481","Evaluation of Study Experiences of Neuroendocrine Tumor Patients",[],"2026-05-13T02:55:06.396524Z",{"nct_id":112,"title":113,"phases":114,"status":115,"updated_at":116,"content_modified":117},"NCT02270567","RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:05.997056Z","2026-06-16T05:54:07.950523Z",[],[120,124,127,131,135,138,141,144,147,150,154,157,160,164,167,170],{"state":121,"count":122,"slug":123},"California",7,"california",{"state":125,"count":122,"slug":126},"New York","new-york",{"state":128,"count":129,"slug":130},"Pennsylvania",6,"pennsylvania",{"state":132,"count":133,"slug":134},"Arizona",5,"arizona",{"state":136,"count":133,"slug":137},"Florida","florida",{"state":139,"count":133,"slug":140},"Michigan","michigan",{"state":142,"count":133,"slug":143},"Minnesota","minnesota",{"state":145,"count":133,"slug":146},"Ohio","ohio",{"state":148,"count":133,"slug":149},"Texas","texas",{"state":151,"count":152,"slug":153},"Connecticut",4,"connecticut",{"state":155,"count":152,"slug":156},"Massachusetts","massachusetts",{"state":158,"count":152,"slug":159},"Wisconsin","wisconsin",{"state":161,"count":162,"slug":163},"Illinois",3,"illinois",{"state":165,"count":162,"slug":166},"Maryland","maryland",{"state":168,"count":162,"slug":169},"North Carolina","north-carolina",{"state":171,"count":162,"slug":172},"Utah","utah"]